SCHEMBL22410996

SCHEMBL22410996

CN1CCN(c2cccc3c2OC(C(=O)Nc2ccc(N4C(=O)CN(C)C4=O)cc2)CC3)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1B P28222 2/20 0.53
▸ KCNH2 Q12809 1/20 0.53
▸ NFKB1 P19838 8/20 0.40
▸ NFKB2 Q00653 8/20 0.40
▸ RELA Q04206 8/20 0.40
▸ NPC1 O15118 3/20 0.40
▸ RAB9A P51151 3/20 0.40
▸ PDE7A Q13946 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ LMNA P02545 2/20 0.37
▸ TSHR P16473 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ HTR1A P08908 1/20 0.36
▸ HTR1D P28221 1/20 0.36
▸ HTR2C P28335 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ DRD2 P14416 1/20 0.36
▸ HTR2A P28223 1/20 0.36
▸ DRD3 P35462 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5308377 0.87 HTR1B (0.57) HTR1BKCNH2NFKB1NFKB2RELA
SCHEMBL5308304 0.86 HTR1B (0.74) HTR1BKCNH2NFKB1NFKB2RELA
SCHEMBL14529628 0.85 HTR1B (0.55) HTR1BKCNH2NFKB1NFKB2RELA
SCHEMBL14263999 0.84 HTR1B (0.73) HTR1BKCNH2NFKB1NFKB2RELA
SCHEMBL14370170 0.84 HTR1B (0.73) HTR1BKCNH2NFKB1NFKB2RELA
SCHEMBL5354642 0.84 HTR1B (0.73) HTR1BKCNH2NFKB1NFKB2RELA
SCHEMBL22411092 0.75 HTR1B (0.49) HTR1BKCNH2NFKB1NFKB2RELA
SCHEMBL5309051 0.75 HTR1B (0.58) HTR1BKCNH2NFKB1NFKB2RELA
SCHEMBL5332970 0.74 HTR1B (0.76) HTR1BKCNH2NFKB1NFKB2RELA
SCHEMBL4987894 0.74 HTR1B (0.43) HTR1BKCNH2ALDH1A1LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020183011-A1 HTR1D INHIBITORS AND USES THEREOF IN THE TREATMENT OF CANCER INSTITUT CURIE (FR) 2020-09-17 — — WO disclosed
Send feedback